My mind is empty and it need sleep right now! 🥱😴🛌 #goodnight

$SERV $UBER Serve Robotics and Little Caesars have partnered to offer autonomous robot pizza delivery through Uber Eats. Deliveries are currently available in the Los Angeles area.

📉 Unfortunately, a lackluster earnings report for AMD. I was afraid of weak EPS, and it came true. At least there are positive signals on the forward guidance side. However, when expectations are set high, high price volatility is inevitable. If we hold above $170, perhaps even close the week above this level, we will have survived with minimal damage. The market loves to exaggerate. Conversely, if a correction is possible, a dip to $140-$150 could be a buying opportunity for those looking to add to their portfolio. 📢 Here are my key points: • Q3 guidance does not include the MI308 revenues planned for sale to China. The sale is still awaiting approval. However, there is a large amount of equipment in stock, ready for immediate shipment. • We still haven't seen the expected AI boom. Lisa Su points to the MI350 ramp-up for this. The market and investors now want to see results. The second half of 2025 is critical.

https://cointelegraph.com/news/indonesia-exploring-bitcoin-reserve-strategy #cryptonews #indonesia #bitcoin #changemakersnft

Trump's New Tariff Move: 250% Tax on Medicines Possible 🔹 Tariffs planned for the chip and pharmaceutical sectors 🔹 Taxes on medicine imports could be raised from 150% to 250% 🟣 Pressure on global supply chains could increase.

A New Era in the US-China Truce 🔹 Trump: "Trade deal is very close" 🔹 A package focused on mutual tax reductions and rare earths 🟡 A sign of short-term easing in global risk appetite.

#GDPNow GDPNow has raised its Q3 growth forecast from +2.1% to +2.5%. The growth rate of the US economy, or real GDP (GDP) growth rate, is one of the most important indicators of economic activity. However, official growth figures are often released with a lag. That's where the GDPNow model, developed by the Atlanta Fed, comes in! 🏦✨ GDPNow uses available economic data for a given period to generate a "nowcast" economic growth forecast before the official release.

Novo Nordisk's Q2 earnings report fell short of expectations, but sales of its weight-loss drug Wegovy were impressive! 🟢 However, due to competition and slowing GLP-1 growth, the company lowered its full-year guidance and is considering a CEO change. 📉 #NovoNordisk #NVO #StockMarket #Finance #Wegovy #Ozempic #EarningsReport

I liked yesterday's pullback, as my expectations for AMD are focused on the second half of the year. I'll be able to buy some more shares. Because Chinese export restrictions haven't been clarified, they've been forced to write off their inventory as a loss, hurting their profitability. The effect is temporary. The game will change in the second half.